Staphylococcal proteases aid in evasion of the human complement system

Journal of Innate Immunity

Volumn 6, Issue 1, 2014, Pages 31-46

  Jusko, Monika ^a   Potempa, Jan ^b,c   Kantyka, Tomasz ^b   Bielecka, Ewa ^b   Miller, Halie K ^d   Kalinska, Magdalena ^b   Dubin, Grzegorz ^b   Garred, Peter ^e   Shaw, Lindsey N ^d   Blom, Anna M ^a  

^a LUND UNIVERSITY   (Sweden)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Complement; Immune evasion; Proteases; Staphylococcus aureus; Virulence factors

Indexed keywords

BACTERIAL ENZYME; CYSTEINE PROTEINASE; METALLOPROTEINASE; SERINE PROTEINASE; STAPHOPAIN A; STAPHOPAIN B; UNCLASSIFIED DRUG; ANAPHYLATOXIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5B; COMPLEMENT FACTOR; FICOLIN 1; FICOLIN 3; LECTIN; METALLOPROTEINASE AUR; PROTEINASE; SERINE PROTEINASE V8;

ARTICLE; BACTERIUM MUTANT; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; ENZYME DEGRADATION; HEMOLYSIS; HUMAN; IMMUNE EVASION; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; COMPLEMENT INHIBITION; FLOW CYTOMETRY; LEUKOCYTE MIGRATION; NEUTROPHIL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; SERUM; SILVER STAINING;

COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; CYSTEINE ENDOPEPTIDASES; HEMOLYSIS; HUMANS; IMMUNE EVASION; METALLOENDOPEPTIDASES; SERINE ENDOPEPTIDASES; SERUM; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84893682791     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000351458     Document Type: Article

References (57)

1. Kluytmans J, van Belkum A, Verbrugh H: Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10: 505-520
2. Lowy FD: Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-532
3. Foster TJ: Colonization and infection of the human host by staphylococci: Adhesion, survival and immune evasion. Vet Dermatol 2009; 20: 456-470
4. Lambris JD, Ricklin D, Geisbrecht BV: Complement evasion by human pathogens. Nat Rev Microbiol 2008; 6: 132-142
5. Serruto D, Rappuoli R, Scarselli M, Gros P, van Strijp JA: Molecular mechanisms of complement evasion: Learning from staphylococci and meningococci. Nat Rev Microbiol 2010; 8: 393-399
6. Jusko M, Potempa J, Karim AY, Ksiazek M, Riesbeck K, Garred P, Eick S, Blom AM: A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system. J Immunol 2012; 188: 2338-2349
7. Popadiak K, Potempa J, Riesbeck K, Blom AM: Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system. J Immunol 2007; 178: 7242-7250
8. Potempa M, Potempa J, Kantyka T, Nguyen KA, Wawrzonek K, Manandhar SP, Popadiak K, Riesbeck K, Eick S, Blom AM: Interpain A, a cysteine proteinase from Prevotella intermedia, inhibits complement by degrading complement factor C3. PLoS Pathog 2009; 5:e1000316
9. Shaw L, Golonka E, Potempa J, Foster SJ: The role and regulation of the extracellular proteases of Staphylococcus aureus. Microbiology 2004; 150: 217-228
10. Potempa J, Pike RN: Corruption of innate immunity by bacterial proteases. J Innate Immun 2009; 1: 70-87
11. Potempa J, Watorek W, Travis J: The inactivation of human plasma alpha 1-proteinase inhibitor by proteinases from Staphylococcus aureus. J Biol Chem 1986; 261: 14330-14334
12. Potempa J, Fedak D, Dubin A, Mast A, Travis J: Proteolytic inactivation of alpha-1-Antichymotrypsin. Sites of cleavage and generation of chemotactic activity. J Biol Chem 1991; 266: 21482-21487
13. Ohbayashi T, Irie A, Murakami Y, Nowak M, Potempa J, Nishimura Y, Shinohara M, Imamura T: Degradation of fibrinogen and collagen by staphopains, cysteine proteases released from Staphylococcus aureus. Microbiology 2011; 157: 786-792
14. Potempa J, Dubin A, Korzus G, Travis J: Degradation of elastin by a cysteine proteinase from Staphylococcus aureus. J Biol Chem 1988; 263: 2664-2667
15. Smagur J, Guzik K, Bzowska M, Kuzak M, Zarebski M, Kantyka T, Walski M, Gajkowska B, Potempa J: Staphylococcal cysteine protease staphopain B (SspB) induces rapid engulfment of human neutrophils and monocytes by macrophages. Biol Chem 2009; 390: 361-371
16. Prokesova L, Potuznikova B, Potempa J, Zikan J, Radl J, Hachova L, Baran K, Porwit-Bobr Z, John C: Cleavage of human immunoglobulins by serine proteinase from Staphylococcus aureus. Immunol Lett 1992; 31: 259-265
17. Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J: Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 2004; 48: 4673-4679
18. Laarman AJ, Ruyken M, Malone CL, van Strijp JA, Horswill AR, Rooijakkers SH: Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion. J Immunol 2011; 186: 6445-6453
19. Wegrzynowicz Z, Heczko PB, Drapeau GR, Jeljaszewicz J, Pulverer G: Prothrombin activation by a metalloprotease from Staphylococcus aureus. J Clin Microbiol 1980; 12: 138-139
20. Imamura T, Tanase S, Szmyd G, Kozik A, Travis J, Potempa J: Induction of vascular leakage through release of bradykinin and a novel kinin by cysteine proteinases from Staphylococcus aureus. J Exp Med 2005; 201: 1669-1676
21. Molla A, Yamamoto T, Akaike T, Miyoshi S, Maeda H: Activation of Hageman factor and prekallikrein and generation of kinin by various microbial proteinases. J Biol Chem 1989; 264: 10589-10594
22. Arvidson S, Holme T, Lindholm B: Studies on extracellular proteolytic enzymes from Staphylococcus aureus. I. Purification and characterization of one neutral and one alkaline protease. Biochim Biophys Acta 1973; 302: 135-148
23. Drapeau GR: Protease from Staphyloccus aureus. Methods Enzymol 1976; 45: 469-475
24. Popowicz GM, Dubin G, Stec-Niemczyk J, Czarny A, Dubin A, Potempa J, Holak TA: Functional and structural characterization of Spl proteases from Staphylococcus aureus. J Mol Biol 2006; 358: 270-279
25. Munthe-Fog L, Hummelshoj T, Hansen BE, Koch C, Madsen HO, Skjodt K, Garred P: The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels. Scand J Immunol 2007; 65: 383-392
26. Munthe-Fog L, Hummelshoj T, Ma YJ, Hansen BE, Koch C, Madsen HO, Skjodt K, Garred P: Characterization of a polymorphism in the coding sequence of FCN3 resulting in a Ficolin-3 (Hakata antigen) deficiency state. Mol Immunol 2008; 45: 2660-2666
27. Hein E, Honore C, Skjoedt MO, Munthe-Fog L, Hummelshoj T, Garred P: Functional analysis of Ficolin-3 mediated complement activation. PLoS One 2010; 5:e15443
28. Amara U, Flierl MA, Rittirsch D, Klos A, Chen H, Acker B, Bruckner UB, Nilsson B, Gebhard F, Lambris JD, Huber-Lang M: Molecular intercommunication between the complement and coagulation systems. J Immunol 2010; 185: 5628-5636
29. Mollnes TE, Brekke OL, Fung M, Fure H, Christiansen D, Bergseth G, Videm V, Lappegard KT, Kohl J, Lambris JD: Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 2002; 100: 1869-1877
30. Karlsson A, Arvidson S: Variation in extracellular protease production among clinical isolates of Staphylococcus aureus due to different levels of expression of the protease repressor SarA. Infect Immun 2002; 70: 4239-4246
31. Oogai Y, Matsuo M, Hashimoto M, Kato F, Sugai M, Komatsuzawa H: Expression of virulence factors by Staphylococcus aureus grown in serum. Appl Environ Microbiol 2011; 77: 8097-8105
32. Abdelnour A, Arvidson S, Bremell T, Ryden C, Tarkowski A: The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun 1993; 61: 3879-3885
33. Cheung AL, Eberhardt KJ, Chung E, Yeaman MR, Sullam PM, Ramos M, Bayer AS: Diminished virulence of a sar-/agr-mutant of Staphylococcus aureus in the rabbit model of endocarditis. J Clin Invest 1994; 94: 1815-1822
34. Chan PF, Foster SJ: Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus. J Bacteriol 1998; 180: 6232-6241
35. McGavin MJ, Zahradka C, Rice K, Scott JE: Modification of the Staphylococcus aureus fibronectin binding phenotype by V8 protease. Infect Immun 1997; 65: 2621-2628
36. McAleese FM, Walsh EJ, Sieprawska M, Potempa J, Foster TJ: Loss of clumping factor B fibrinogen binding activity by Staphylococcus aureus involves cessation of transcription, shedding and cleavage by metalloprotease. J Biol Chem 2001; 276: 29969-29978
37. Timar KK, Dallos A, Kiss M, Husz S, Bos JD, Asghar SS: Expression of terminal complement components by human keratinocytes. Mol Immunol 2007; 44: 2578-2586
38. Dovezenski N, Billetta R, Gigli I: Expression and localization of proteins of the complement system in human skin. J Clin Invest 1992; 90: 2000-2012
39. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW: Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000; 68: 688-693
40. Lynch NJ, Roscher S, Hartung T, Morath S, Matsushita M, Maennel DN, Kuraya M, Fujita T, Schwaeble WJ: L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. J Immunol 2004; 172: 1198-1202
41. Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, Agata T, Mizunoe Y: Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 2010; 465: 346-349
42. Yuste J, Ali S, Sriskandan S, Hyams C, Botto M, Brown JS: Roles of the alternative complement pathway and C1q during innate immunity to Streptococcus pyogenes. J Immunol 2006; 176: 6112-6120
43. Alvarez-Dominguez C, Carrasco-Marin E, Leyva-Cobian F: Role of complement component C1q in phagocytosis of Listeria monocytogenes by murine macrophage-like cell lines. Infect Immun 1993; 61: 3664-3672
44. Ward PA: The harmful role of C5a on innate immunity in sepsis. J Innate Immun 2010; 2: 439-445
45. Solomkin JS, Jenkins MK, Nelson RD, Chenoweth D, Simmons RL: Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation. Surgery 1981; 90: 319-327
46. Riedemann NC, Guo RF, Bernacki KD, Reuben JS, Laudes IJ, Neff TA, Gao H, Speyer C, Sarma VJ, Zetoune FS, Ward PA: Regulation by C5a of neutrophil activation during sepsis. Immunity 2003; 19: 193-202
47. Guo RF, Riedemann NC, Bernacki KD, Sarma VJ, Laudes IJ, Reuben JS, Younkin EM, Neff TA, Paulauskis JD, Zetoune FS, Ward PA: Neutrophil C5a receptor and the outcome in a rat model of sepsis. FASEB J 2003; 17: 1889-1891
48. Smagur J, Guzik K, Magiera L, Bzowska M, Gruca M, Thogersen IB, Enghild JJ, Potempa J: A new pathway of staphylococcal pathogenesis: Apoptosis-like death induced by staphopain B in human neutrophils and monocytes. J Innate Immun 2009; 1: 98-108
49. Wang M, Krauss JL, Domon H, Hosur KB, Liang S, Magotti P, Triantafilou M, Triantafilou K, Lambris JD, Hajishengallis G: Microbial hijacking of complement-Toll-like receptor crosstalk. Sci Signal 2010; 3:ra11
50. Voyich JM, Braughton KR, Sturdevant DE, Whitney AR, Said-Salim B, Porcella SF, Long RD, Dorward DW, Gardner DJ, Kreiswirth BN, Musser JM, DeLeo FR: Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 2005; 175: 3907-3919
51. Kubica M, Guzik K, Koziel J, Zarebski M, Richter W, Gajkowska B, Golda A, Maciag-Gudowska A, Brix K, Shaw L, Foster T, Potempa J: A potential new pathway for Staphylococcus aureus dissemination: The silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS One 2008; 3:e1409
52. Pasupuleti M, Walse B, Nordahl EA, Morgelin M, Malmsten M, Schmidtchen A: Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans. J Biol Chem 2007; 282: 2520-2528
53. Drapeau GR: Role of metalloprotease in activation of the precursor of staphylococcal protease. J Bacteriol 1978; 136: 607-613
54. Nickerson NN, Joag V, McGavin MJ: Rapid autocatalytic activation of the M4 metalloprotease aureolysin is controlled by a conserved N-Terminal fungalysin-Thermolysin-propeptide domain. Mol Microbiol 2008; 69: 1530-1543
55. Nickerson N, Ip J, Passos DT, McGavin MJ: Comparison of staphopain A (ScpA) and B (Sspb) precursor activation mechanisms reveals unique secretion kinetics of proSspB (staphopain b), and a different interaction with its cognate staphostatin, SspC. Mol Microbiol 2010; 75: 161-177
56. Kolar SL, Antonio Ibarra J, Rivera FE, Mootz JM, Davenport JE, Stevens SM, Horswill AR, Shaw LN: Extracellular proteases are key mediators of Staphylococcus aureus virulence via the global modulation of virulence-determinant stability. Microbiologyopen 2013; 2: 18-34
57. Jones RC, Deck J, Edmondson RD, Hart ME: Relative quantitative comparisons of the extracellular protein profiles of Staphylococcus aureus UAMS-1 and its sarA, agr, and sarA agr regulatory mutants using one-dimensional polyacrylamide gel electrophoresis and nanocapillary liquid chromatography coupled with tandem mass spectrometry. J Bacteriol 2008; 190: 5265-5278